Back to results
US 12,091,391 B2Granted
Reagents and methods for bioorthogonal labeling of biomolecules in living cells
AssigneeOregon State University
InventorsRyan A. Mehl, Robert Blizzard
Life of this patent
Estimating the term…
Abstract
Tetrazine non-canonical amino acids, methods for genetic encoding proteins and polypeptides using the tetrazine amino acids, proteins and polypeptides comprising the tetrazine amino acids, and compositions comprising the proteins and polypeptides having at least one post-translational modification thereof comprising in vivo reaction with the incorporated tetrazine amino acid and a second molecule.
Claims7
A method for making a protein or a polypeptide, comprising:
- culturing a cell in a medium including a tetrazine amino acid, the tetrazine amino acid comprising an amino acid bound directly to a tetrazine via a carbon link, wherein the cell includes:
- a nucleic acid that encodes a protein or a polypeptide and comprises a selector codon;
- an orthogonal tRNA that is specific for the tetrazine amino acid and that recognizes an orthogonal Methanococcus jannaschii (Mj) aminoacyl-tRNA synthetase that is specific for the tetrazine amino acid and recognizes the selector codon, and
- the orthogonal Mj aminoacyl-tRNA synthetase aminoacylates the orthogonal tRNA with the tetrazine amino acid;
- and
- in the cultured cell and using the orthogonal Mj aminoacyl-tRNA synthetase and the orthogonal tRNA, incorporating the tetrazine amino acid into the protein or the polypeptide to provide a protein or polypeptide having a tetrazine amino acid residue bound to the protein or the polypeptide, wherein the tetrazine amino acid is selected from the group consisting of 4-(6-methyl-s-tetrazin-3-yl)phenylalanine (Tet-v2.0-methyl), 4-(6-ethyl-s-tetrazin-3-yl)phenylalanine (Tet-v2.0-ethyl), 4-(6-isopropyl-s-tetrazin-3-yl)phenylalanine (Tet-v2.0-isopropyl), and 4-(6-butyl-s-tetrazin-3-yl)phenylalanine (Tet-v2.0-n-butyl), wherein the orthogonal Mj aminoacyl-tRNA synthetase comprises modified amino acids at positions 32, 65, 108, 109, 158, and 162, and wherein the modified amino acids are:
- Ala or Gly at position 32;
- Ala, Ser, Val, or Gln at position 65;
- Glu, Gln, His, Asp, Ser, Leu, or Ala at position 108;
- His, Glu, Ser, Asp, or Pro at position 109;
- Gly, Ser, or Asn at position 158;
- and
- Ser, Ala, Gly, or Asn at position 162.
10 more elements
Dependencies are inferred from the claim text.